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Summary
Background: Diagnosis of acute myocardial infarction (AMI) rests upon clinical, electrocardiographic and biochemical
parameters. Previous studies reported AMI patients who present with non-specific ECGs.
Objectives: To examine clinical or demographic features of AMI patients presenting with or without ECG changes
and assess the impact of these ECGs on treatment and outcome.
Methods: Using the AMIS Plus data, patients admitted between 2003 and 2008 with a definite diagnosis of AMI
(clinical symptoms, elevated troponin levels) were stratified according to the admission ECG into group 1 with normal/
non-specific ECGs and group 2 with ECG changes.
Results: Of 14 957 patients, 1085 (7.3%) belonged to group 1 and 13 872 (92.7%) to group 2. There were no
differences between the two groups in age (65.9 yr vs. 65.4 yr), gender (28% female), diabetes (19% vs. 18%),
hypertension (61% vs. 59%), family history (35% vs. 33%) or smoking (37% vs. 38%). Dyslipidaemia (62% vs. 56%; p
<0.001), history of CAD (39% vs. 35%; p = 0.023) and obesity (BMI >30 kg/m2 [23% vs. 19%; p = 0.003]) were more
frequent in group 1 who were admitted longer after symptom onset (280 min vs. 230 min). Patients in group 1 were
exposed to less intensive pharmacological and interventional treatments (aspirin [93.6% vs. 95.3%; p = 0.012],
clopidogrel [70% vs. 73%; p = 0.046], unfractionated heparin [59% vs. 65%; p <0.001], ACE inhibitors or angiotensin II
antagonists [46% vs. 53%; p <0.001]). However, therapy with beta-blockers (72% vs. 70%), statins (75% vs. 76%) and
nitrates (59% vs. 57%) did not differ between groups. Patients in group 1 underwent PCI significantly less frequently
(69% vs. 77%) with a longer hospital delay (589 min vs. 96 min). No differences were found for reinfarction (both 1.4%)
and a cerebrovascular event (0.4% vs. 0.8%). Cardiogenic shock (5% vs. 2%; p <0.001) and mortality during
hospitalisation were higher in group 2 (6% vs. 3%; p <0.001). A normal/non-specific ECG on admission was not an
independent predictor of in-hospital mortality (OR 0.61; 95% CI 0.34–1.11; p = 0.104).
Conclusions: Despite less intensive treatment, AMI patients who presented with a normal/non-specific ECG
developed cardiogenic shock less frequently during their hospitalisation and had a lower crude mortality rate compared to
those with ECG changes on admission. Nevertheless, reinfarctions and cerebrovascular events occurred evenly in all AMI
patients, regardless of their admission ECG.
Key words: acute myocardial infarction; electrocardiogram; treatment; outcome
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Introduction
Evaluating patients with acute myocardial infarction (AMI) and administering the best available therapy remains a
challenge for all practising physicians. Strategic decision-making and clinical assessments leading to a diagnosis
suggesting AMI need to take place rapidly in order to justify treatment and optimise outcome. Current diagnostic
guidelines rest upon clinical, electrocardiographic and biochemical evidence. The ECG has become an indispensable tool
for all clinicians dealing with suspected AMI. ECG evidence is obtained rapidly, is widely available and shows reliable
ischaemic signs; it therefore plays a key role in the early diagnosis of AMI and, by dividing AMI patients into ST
elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) groups, provides the criteria on which the current
treatment guidelines are based [1–2].
However, there are AMI patients who present with an ECG lacking all the expected changes and whose diagnosis
must be established on the basis of the presenting symptoms and cardiac markers. Several previous studies suggested that
AMI patients with a normal ECG can be stratified into a low-risk group and have a favourable prognosis [3–5].
The present study aims to assess AMI patients with a normal/nonspecific ECG on admission and compare them with
regard to clinical features, treatment and outcome with patients whose admission ECG shows changes.
Methods
The patient data used for this study were provided by AMIS Plus, a nationwide register recording data on hospitalisation
for acute coronary syndromes (ACS). Details of the AMIS Plus Project have been published elsewhere [6–10].
Study population
All patients included in this study fulfilled the criteria for enrolment in the AMIS Plus database and were admitted to
participating hospitals in Switzerland between January 2003 and December 2008 with a diagnosis of AMI, which was
defined as characteristic clinical symptoms and/or a typical ischaemia ECG pattern and troponins, elevated above the
individual cut-off level for AMI of each particular hospital and with a valid ECG on admission. All patients are
considered to have met the criteria for the ESC-ACC 2000 definitions for AMI [11]. Patients with missing data on the on
admission ECG or on the cardiac marker value, and those with a discharge diagnosis of unstable angina, were excluded.
The 12-lead ECG obtained on admission was interpreted by the hospital physicians on duty at that time and the
findings were captured in the AMIS Plus questionnaire. An ECG was defined as abnormal when it showed one or more of
the following changes: ST-segment elevation or depression, T-wave changes, Q-waves, and left or right bundle branch
blocks. Moreover, if an ECG was referred to as abnormal due to ST-segment elevation and/or a presumed new left bundle
branch block, it was categorised as STEMI; if it was referred to as abnormal due to one or more of the other irregularities
mentioned, it was categorised as NSTEMI. An ECG was defined as normal when it showed the usual pattern, i.e. without
pathologic signs, or as non-specific when it showed minor non-ischaemic changes and did not fit the above-mentioned
criteria. The patients who met the inclusion requirements were divided according to the pattern of the ECG on admission
into two groups: Group 1 patients presented with normal/non-specific ECG findings and Group 2 with abnormal ECGs on
admission.
Statistics
Counts and percentages were used to describe discrete variables; means with standard deviation (SD) and median values
with interquartile ranges (IQRs, 25th, 75th percentile) were used for continuous variables. In univariate tests, the chi-
squared test and Fisher’s exact test were used for discrete variables and the unpaired t-test or the Mann-Whitney U test for
continuous variables. A multivariate logistic regression model with backward stepwise variable selection was used to
determine if a normal/non-specific ECG on admission adjusted for age, sex, cardiopulmonary resuscitation before
admission, heart rate, systolic blood pressure, ACS with ST elevation, Killip class, history of coronary artery disease,
hypertension, diabetes, dyslipidaemia, current smoking, obesity (body mass index >30 kg/m2) and primary percutaneous
coronary intervention (PCI) is a predictor of in-hospital mortality. A p value lower than 0.05 was considered statistically
significant. SPSS (version 15.0, SPSS Inc., Chicago, Ill) was used for all statistical analyses.
Original article Swiss Med Wkly. 2010;140:w13078 · www.smw.ch E2
Figure 1
Overview of the patients included in this
study.
Results
Between January 2003 and December 2008, 17 781 patients with an ACS
were enrolled in the AMIS Plus registry. Cardiac marker values were
missing in 991 cases and troponin values were negative in 1731 cases,
which were therefore excluded. Among the 15 059 patients with elevated
cardiac markers indicating AMI, another 102 cases were excluded due to
missing ECG data. The remaining 14 957 patients met the inclusion
criteria.
1085 patients (7.3%) presented with a normal/non-specific ECG and
13 872 (92.7%) had an abnormal ECG. Among the group with an
abnormal ECG, 8803 patients had STEMI (58.9%) and 5069 (33.9%)
NSTEMI (fig. 1)
The baseline characteristics of AMI patients according to their
admission ECG are shown in table 1.
There was no difference between the two groups in age, gender,
diabetes, hypertension, family history of premature CAD or smoking
habits. Dyslipidaemia, history of ischaemic heart disease and obesity
(BMI >30) were significantly more frequent among the patients with a
normal/non-specific ECG. However, they more frequently had lower
Killip classes but similar comorbidities.
Patients with a normal/non-specific ECG presented with a longer
delay (280 min; IQR 130, 835 min) after symptom onset than those with an abnormal ECG (230 min; IQR 115, 654 min),
but this difference was not significant. Moreover, the patients who presented in the first 3 hours after symptom onset more
often had an abnormal ECG (40.7% vs. 34.4%; p = 0.002), whereas a higher percentage of the patients presenting more
than 12 hours after symptom onset (28.0% vs. 23.2%; p = 0.002) had a normal/non-specific ECG (fig. 2).
Patients with a normal/non-specific ECG at admission were given less intensive treatment; both pharmacological and
interventional (table 2). They underwent significantly less frequently early PCI and the interventions took place after a
longer in-hospital delay (589 min, IQR 194, 1449 min vs. 96 min; IQR 35, 341 min). However, performed coronary artery
bypass grafting (CABG) was comparable between both groups.
Angiographic findings have been recorded in AMIS Plus since 2005 and are depicted in figure 3. Patients with a
normal/non-specific ECG (n = 604) showed significantly higher rates of left ventricular ejection fraction (LVEF): the
LVEF was above 50% in 81.3% of these patients, 15.6% had an LVEF between 35% and 50% and 3.1% had an LVEF
below 35%. The rates were lower in the group of patients with an abnormal ECG (n = 7736); 55.4%, 36.6% and 8.0%
respectively.
Despite the differences in therapeutic strategy the two groups had similar rates of re-infarction and cerebrovascular
event, but the patients whose ECG at admission showed changes more often developed cardiogenic shock during their
hospital stay and had a higher in-hospital crude mortality rate of 6.0%, compared with 3.1% in the group with a normal
ECG (OR 1.91: 95%CI 1.36-2.67; P <0.001) (table 3).
In the multivariate logistic regression model a normal/non-specific ECG on admission was not an independent
predictor of in-hospital mortality; adjusted OR was 0.61 with a 95% CI from 0.34–1.11 (P = 0.104). Normal/nonspecific
ECG was the only non-significant variable in this model, whereas age, history of diabetes, smoking, Killip class, STEMI,
history of dyslipidaemia, heart rate, systemic blood pressure, resuscitation prior to admission and PCI were significant.
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Table 1
Baseline characteristics according to the patient’s ECG on admission.
ELECTROCARDIOGRAM ON ADMISSION
Normal n = 1085 (7.3%) Abnormal n = 13 872 (92.7%) P-value
Demographics
Women 304/1085 (28.0) 3850/4154 (27.8) 0.86
Men 781/1085 (72.0) 10 022/10 803 (72.2) 0.86
Age for women in years, mean ± SD 71.9 ± 13.2 71.9 ± 12.6 0.96
Age for men in years, mean ± SD 62.9 ± 13.1 63.6 ± 13.1 0.14
BMI, kg/m2, mean ± SD 27.2 ± 4.4 26.8 ± 4.3 0.003
Cardiovascular risk factors
Diabetes 188/1049 (17.9) 2605/13 373 (19.5) 0.22
Dyslipidaemia 582/946 (61.5) 6882/12 212 (56.4) 0.001
Hypertension 626/1027 (61.0) 7882/13 170 (59.8) 0.51
History of ischaemic heart disease 291/744 (39.1) 3636/10 398 (35.0) 0.023
Family history of early CAD 229/651 (35.2) 2706/8094 (33.4) 0.37
Current smoking 368/1001 (36.8) 4922/12 920 (38.1) 0.42
Obesity BMI >30 kg/m2 212/913 (23.2) 2242/11 702 (19.2) 0.003
Clinical presentation
Delay symptom onset to admission median
IQR 25th, 75th
280
130, 835
230
115, 645
<0.001
Pain 898/1062 (84.6) 11016/13 500 (81.6) 0.017
Dyspnoea 256/1035 (24.7) 3555/12 956 (27.4) 0.065
Sinus rhythm 997/1078 (92.5) 12540/13 803 (90.8) 0.005
Atrial fibrillation 481/1078 (4.5) 727/13 803 (5.3) 0.005
Heart rate b.p.m., mean ±SD 76.4 ± 18.2 79.0 ± 20.3 <0.001
Systolic blood pressure mm Hg, mean ±SD 141.1 ± 25.7 135.0 ± 28.4 <0.001
Diastolic blood pressure mm Hg, mean ±SD 81.6 ± 16.3 79.3 ± 17.9 <0.001
Killip classes (%) n = 1081 n =13810 <0.001
Class I 85.9 78.7
Class II 10.4 14.4
Class III 2.6 3.9
Class IV 1.1 3.0
Comorbidities
Past history of myocardial infarction 181/1078 (16.8) 2293/13 656 (16.8) 1.00
Heart failure NYHA III/IV 45/1078 (4.2) 501/13 656 (3.7) 0.41
Moderate to severe renal disease 57/1078 (5.3) 948/13 656 (6.9) 0.041
Neoplastic disease* 69/1078 (6.4) 746/13 656 (5.5) 0.19
* including malignant neoplasm, leukaemia, lymphoma, metastatic solid tumour
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Figure 2
Delay from symptom onset to presentation in
AMI patients according to the ECG on
admission.
Table 2
Immediate therapy according to the patient’s ECG on admission.
ELECTROCARDIOGRAM ON ADMISSION
Normal n = 1085 (7.3%) Abnormal n = 13 872 (92.7%) P-value
Immediate pharmacological therapy
Aspirin 1014/1083 (93.6) 13 182/13 828 (95.3) 0.013
Clopidogrel 761/1081 (70.4) 10 089/13 78 (73.2) 0.046
GP IIb/IIIa antagonist 244/1071 (22.8) 4944/13 700 (36.1) <0.001
UFH 636/1078 (59.0) 8936/13 750 (65.0) <0.001
LMWH 444/1075 (41.3) 4815/13 650 (35.3) <0.001
Beta-blocker 772/1078 (71.6) 9551/13 740 (69.5) 0.16
ACE-inhibitor 410/1075 (38.1) 6481/13 688 (47.3) <0.001
Angiotensin II receptor antagonist 99/1068 (9.3) 874/13 577 (6.4) 0.001
Ca-channel blocker 95/1075 (8.8) 888/13 601 (6.5) 0.004
Nitrate 634/1075 (59.0) 7856/13 704 (57.3) 0.31
Lipid lowering drug 800/1074 (74.5) 10440/13 752 (75.9) 0.30
Interventional therapy
PCI primary 484/1082 (44.7) 8745/13 835 (63.2) <0.001
Any PCI 751/1085 (69.2) 10627/13 872 (76.6) <0.001
Thrombolysis 6/1085 (0.6) 681/13 871 (4.9) <0.001
CABG 62/1045 (6.0) 782/13 489 (5.0) 0.92
Table 3
Early outcome according to the patient’s ECG on admission.
ELECTROCARDIOGRAM ON ADMISSION
Normal n = 1085 (7.3%) Abnormal n = 13 872 (92.7%) P-value
Complications
Cardiogenic shock 24/1076 (2.2) 666/13 711 (4.9) <0.001
Cerebrovascular event 4/1076 (0.4) 115/13 659 (0.8) 0.11
Re-infarction 15/1076 (1.4) 190/13 701 (1.4) 1.00
Death 34/1085 (3.1) 828/13 872 (6.0) <0.001
Data are given as number of analysed patients/number of patients without missing data (percentage).
Discussion
The present study identifies a subgroup of AMI patients who were
admitted with a normal/non-specific ECG, had elevated cardiac enzymes
and were treated for AMI and discharged with a final diagnosis of AMI.
The size of this subgroup is considerable and amounts to 7.3% of all the
patients admitted for AMI participating in the study. This rate is
comparable with the percentage range of AMI patients with a normal
ECG on admission found in earlier studies with similar inclusion criteria,
in which the rates vary from 3% to 17% [4, 12–15]. The broad variation
in the percentages of normal AMI can be explained by the different
criteria defining an ECG pattern as normal/non-specific. This makes
comparison between the various studies difficult [16]. In a study by Welch
et al. [4], as many as 35.1% of the AMI patients studied belonged to the
non-specific group, a rate much higher than in this study simply due to the
ECG classification criteria and not to a completely different patient
collective.
Common clinical or demographic characteristics amongst AMI
patients with a normal/non-specific ECG could not be identified. Their
features and risk factors were very similar to those of the population with an abnormal ECG on admission. These patients
also had a more frequent history of ischaemic heart disease which could cause the organism to adapt successfully to its
hypoxic condition and therefore show a normal ECG despite AMI and perhaps less typical and acute symptoms.
Furthermore, AMI patients presenting with a normal/non-specific ECG were more often obese, which may present
technical difficulties in recording the superficial ECG, resulting in a less accurate reading.
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Figure 3
Angiographic findings in AMI patients with
normal and abnormal ECG at admission.
Similar studies showed that patients with AMI and a normal ECG on
admission were more often male and younger than those with an
abnormal ECG [4, 15]. Findings regarding the rates of prior MI varied.
Patients with a normal ECG were associated with higher [3] or lower [4,
17] rates of prior AMI; in the present study, however, the rates of prior
AMI were the same in both groups.
Despite similar presentation characteristics, the treatment received by
patients with a normal/non-specific ECG was less aggressive. This was
also the case in a similar study [4] which noted that these patients
presented with less typical AMI symptoms and were given their first ECG
after a longer delay. In this study procedures were performed after a
longer interval after symptom onset. These patients received aspirin,
heparin, intravenous beta-blockers or PCI less often but had similar rates
of CABG [4]. The differences in care received are not surprising
considering the normal ECG findings which are likely to entice clinicians into a diagnosis other than AMI before further
examinations have been conducted. In AMI care, time plays a major role and these possible delays may have an impact on
the outcome. However, despite the less aggressive treatment, patients in the present study had lower in-hospital mortality
rates and a more favourable hospital course regarding cardiogenic shock. Nevertheless, these patients were in a critical
situation, since 3.1% died in hospital and several suffered life-threatening complications such as re-infarction and
cerebrovascular events as often as those with an abnormal ECG. The 30-day outcome was similar in patients with and
without changes on their admission ECG in a study by Welch et al. [4].
Several older studies suggested that in patients with suspected AMI and a normal ECG on admission, the ECG on
admission is “better for determining the prognosis than for determining the diagnosis” [5]. The main findings of these
studies associate an initial normal/non-specific ECG with a more favourable outcome including less AMI, less life-
threatening complications and death [3, 5, 17–19]. Fesmire et al. [20] found there was a 14.2 times greater risk of AMI
when the initial ECG was abnormal. Furthermore, the initial ECG as a stratifying tool and was used for separating
patients with suspected AMI into low- and high-risk groups for AMI, complications or death, and became an indicator of
the ward to which the patient was best suited: ICU; CCU; monitored bed or medical bed. A recent study [4], including
only patients with a definite diagnosis of MI, found that patients with AMI and a normal ECG had a 41% lower risk of
hospital death. Although it was not significant, there was a similar 42% lower risk of mortality in this study.
Caceres et al. [12] found that all patients with adverse events had ECG changes prior to the event. When changes
appear in an initially normal ECG they can be taken as a warning for an adverse outcome and an indicator for taking
appropriate action; they can lower expectations of a good prognosis. By following the ECG evolution during
hospitalisation with serial ECG readings, adverse events may be dealt with more efficiently.
It seems surprising that such a large proportion of AMI patients present with a normal ECG and the reasons why this
reliable diagnostic tool fails in its duty cannot be identified in the patients’ features. The reasons suggested up to now for
this are, on the one hand, related to the delay between the time of symptom onset to the time of the first ECG recording or,
on the other hand, to the characteristics of the lesion, such as location and size [12].
First, it may be that the patients who have a normal ECG on admission present very early after symptom onset and the
organic changes are not yet visible on the ECG reading [5, 17, 21]. In the present study, however, the patients who
presented with a normal/non-specific ECG tended to arrive later, with a median time difference of 50 minutes, than those
whose initial ECG showed abnormalities. Their first ECG was recorded after a longer delay [4]. Hence it was not possible
to correlate the time between the onset of symptoms and the patients’ admission with the probability that the initial ECG
would have an abnormal pattern, which is in accordance with findings by Caceres et al. [12].
Following this delay hypothesis, Singer et al. [14] assessed the time that an ECG remained normal after symptom
onset. No matter how long an ECG remains normal, it does not rule out AMI. Hence there are organic changes that the
ECG cannot detect: a normal ECG could then be associated with a particular type of lesion.
Secondly, lower peak CK levels have been associated with smaller MIs [22] and have also been found frequently in
AMI patients presenting with a normal ECG [3, 5, 12, 15, 17, 23]. A minimal infarct size may be required for recognition
by a superficial ECG. Ward et al. found that the infarction needs to cover at least 3% of the left ventricle [24].
The final reason for silent electrocardiographic findings in MI may lie in the location of the lesion, which may also be
an obstacle to detection by the ECG, since up to 50% of infarctions in the left circumflex distribution may be silent [25],
and the extent of the surface ECG’s abnormality depends on the location of the lesion [26–27]. Accordingly, an ECG can
overlook a lesion, which explains why 98% of the patients with a normal/non-specific ECG in this study showed
abnormal coronary angiographic findings. Zalenski et al. [15] analysed the angiographic findings of a group of patients
with a normal initial ECG and associated a normal ECG with a culprit lesion in a peripheral branch.
Deficient in diagnostic evidence, a normal admission ECG in an ischaemic patient may delay the final diagnosis and
initiation of treatment, in which absence of a time delay plays a major role in a favourable outcome. The rates of missed
diagnoses and inadvertent discharge of AMI patients vary between 2% to 8% of all presenting AMI patients [13] and one
of the factors associated with discharge with AMI rather than hospitalisation was a normal ECG [13, 17, 28]. A non-
admitted AMI patient had a 1.9 times higher risk of death compared to those admitted [13]. Moreover, the time lapse
between presentation and definite diagnosis of AMI was longer in patients with a normal ECG, despite the same
presentation time [4, 17], and this may also hold back the start of therapy and worsen the outcome.
Original article Swiss Med Wkly. 2010;140:w13078 · www.smw.ch E6
Therefore, as long as the diagnosis is accurate and patients are hospitalised and treated accordingly, a normal ECG on
admission can be interpreted as a predictor of a better short-term outcome. Recognition of a silent electrocardiographic
MI requires all the physician’s attention and clinical skills to ensure the correct diagnosis and the appropriate care.
However, to improve diagnosis in coronary care, repeated cardiac marker measurements are needed to strengthen the
findings. The latest development in troponin assays [29–30] may, thanks to their higher sensitivity and rapid availability,
improve the therapeutic pathway and represent the missing cornerstone for AMI patients.
Limitations
The limitations encountered are common to all registries. Data are only available on the admission ECG and symptoms;
all subsequent ECG readings and symptom evolution were not recorded in the registry and therefore preclude any further
analysis. The AMIS registry records coronary angiographic findings located in one or more of the main vessels (one-,
two- or three-vessel disease and LCA yes/no) which prevents study of the relationship between peripheral lesions and a
normal ECG.
In the present study the ECG readings were not centralised and were undertaken by the hospital physicians on duty.
All the patients in this study were admitted with suspected AMI and had indeed a final discharge diagnosis of AMI; the
temporal relation between admission ECG and diagnosis was not recorded. The cardiac marker measurements of the
patients included were undertaken in their respective hospitals. The technical devices used may diverge and different cut-
off values for MI could cause an unwitting bias.
However, the large number of patients analysed added to our understanding of AMI and pointed up the necessity of
investigating further diagnostic pathways to rapid identification and risk assessment of patients presenting with symptoms
of cardiac ischaemia without the expected ECG changes.
Conclusion
Normal or non-specific ECG changes in patients admitted for suspected AMI do not rule out AMI. Moreover, AMI
patients presenting with a normal/non-specific ECG are not uncommon and cannot be categorised by common clinical or
demographic features. They are treated less aggressively and after a longer time lapse. Although these patients had lower
in-hospital mortality and less frequent cardiogenic shock, they have a risk of re-infarction and cerebrovascular events
similar to patients with an abnormal ECG on admission. Further studies are needed to assess whether these particular MI
patients could hope for an even more favourable outcome if they received care with the same intensity as those who
present with an abnormal ECG, and also to find a diagnostic pathway to rapid identification of AMI when ECG evidence
is lacking.
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